2022 - Research.com Best Scientist Award
2000 - Gifted Teacher Award, American College of Cardiology (ACC)
The scientist’s investigation covers issues in Internal medicine, Cardiology, Coronary artery disease, Nuclear medicine and Perfusion. His work carried out in the field of Internal medicine brings together such families of science as Diabetes mellitus and Surgery. His Coronary artery disease study integrates concerns from other disciplines, such as Radiology, Stenosis, Scintigraphy and Coronary arteries.
His Radiology research focuses on Receiver operating characteristic and how it relates to Area under the curve. His research in Nuclear medicine tackles topics such as Tomography which are related to areas like Imaging phantom. He studied Perfusion and Gated SPECT that intersect with Gated Blood-Pool Imaging.
His main research concerns Internal medicine, Cardiology, Coronary artery disease, Radiology and Nuclear medicine. When carried out as part of a general Internal medicine research project, his work on Myocardial infarction, Asymptomatic, Stenosis and Revascularization is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His research brings together the fields of Surgery and Cardiology.
Daniel S. Berman interconnects Angiography, Proportional hazards model, Chest pain and Hazard ratio in the investigation of issues within Coronary artery disease. His Nuclear medicine study incorporates themes from Tomography and Reproducibility. His Perfusion course of study focuses on Single-photon emission computed tomography and Emission computed tomography.
His primary scientific interests are in Internal medicine, Cardiology, Coronary artery disease, Nuclear medicine and Radiology. His work in the fields of Internal medicine, such as Myocardial infarction, Hazard ratio, Coronary artery calcium and Stenosis, overlaps with other areas such as In patient. The study incorporates disciplines such as Proportional hazards model and Cohort in addition to Hazard ratio.
His research investigates the connection between Coronary artery disease and topics such as Computed tomography angiography that intersect with problems in Predictive value of tests. The various areas that Daniel S. Berman examines in his Nuclear medicine study include Angiography and Reproducibility. His Myocardial perfusion imaging research incorporates themes from Single-photon emission computed tomography and Emission computed tomography.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Coronary artery disease, Radiology and Stenosis. His study in Hazard ratio, Asymptomatic, Confidence interval, Cohort and Proportional hazards model falls under the purview of Internal medicine. Myocardial infarction, Mace, Ejection fraction, Ischemia and Artery are the core of his Cardiology study.
His Coronary artery disease research integrates issues from Computed tomography angiography, Framingham Risk Score and Nuclear medicine. His work on Angiography and Magnetic resonance imaging as part of his general Radiology study is frequently connected to CAD and In patient, thereby bridging the divide between different branches of science. The concepts of his Stenosis study are interwoven with issues in Coronary ct angiography and Severity of illness.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
William E. Boden;Koon K. Teo;Pamela M. Hartigan;David J. Maron.
The New England Journal of Medicine (2007)
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)
Francis J. Klocke;Michael G. Baird;Beverly H. Lorell;Timothy M. Bateman.
Journal of the American College of Cardiology (2003)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw;Daniel S. Berman;David J. Maron;G. B. John Mancini.
Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography
Rory Hachamovitch;Sean W. Hayes;John D. Friedman;Ishac Cohen.
Incremental Prognostic Value of Myocardial Perfusion Single Photon Emission Computed Tomography for the Prediction of Cardiac Death Differential Stratification for Risk of Cardiac Death and Myocardial Infarction
Rory Hachamovitch;Daniel S. Berman;Leslee J. Shaw;Hosen Kiat;Hosen Kiat.
Automatic quantification of ejection fraction from gated myocardial perfusion SPECT.
G Germano;H Kiat;P B Kavanagh;M Moriel.
The Journal of Nuclear Medicine (1995)
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial
Raj R Makkar;Rachel R Smith;Ke Cheng;Konstantinos Malliaras.
The Lancet (2012)
Long-Term Prognosis Associated With Coronary Calcification: Observations From a Registry of 25,253 Patients
Matthew J. Budoff;Leslee J. Shaw;Sandy T. Liu;Steven R. Weinstein.
Journal of the American College of Cardiology (2007)
The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis
Timothy D. Henry;Brian H. Annex;George R. McKendall;Michael A. Azrin.
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality.
Leslee J. Shaw;Paolo Raggi;Enrique Schisterman;Daniel S. Berman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: